Milikem Pharmaceuticals Private Limited
Founded in 2007 and headquartered in Maharashtra, India.
2007 | Mumbai, Maharashtra (India) | Inactive
Milikem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2008
About Milikem Pharmaceuticals
Milikem Pharmaceuticals Private Limited (MPPL) is Strike Off company established on 07 Apr 2007 with its office registered at Mumbai, Maharashtra, India and has been running since 17 Year, 10 Months with a paid up capital of 0.10 M. According to MCA records, 4 Directors are linked to this company as of 01 Apr 2024.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MH2007PTC169739
- Company No.
169739
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2007
- Date of AGM
30 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals
Pharmaceuticals
Who are the key members and board of directors at Milikem Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemal Patel  | Director | 07-Apr-2007 | Current |
| Milind Phadke | Director | 07-Apr-2007 | Current |
| Madhuri Phadke | Director | 07-Apr-2007 | Current |
| Ami Patel | Director | 07-Apr-2007 | Current |
Financial Performance of Milikem Pharmaceuticals.
Enhance accessibility to Milikem Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Milikem Pharmaceuticals?
Unlock access to Milikem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Apister Lifesciences Private LimitedHemal Patel is a mutual person
Maharshi Pharma Chem Private LimitedHemal Patel is a mutual person
- D Raja Pharmaceuticals Llp
Hemal Patel is a mutual person
- Amigen Biosciences Private Limited
Hemal Patel is a mutual person
- Vidman Healthcare Private Limited
Hemal Patel is a mutual person
- Genpep Pharmaceuticals Private Limited
Hemal Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Milikem Pharmaceuticals?
Unlock and access historical data on people associated with Milikem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Milikem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Milikem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.